Vitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelination

Document Type: Original Article


Department of Biology, Faculty of Science, Urmia University, Urmia, Iran


Objective(s):Multiple sclerosis (MS) is a demyelinating disease. The prevalence of MS is highest where environmental supplies of vitamin D are low. Cognitive deficits have been observed in patients with MS. Oxidative damage may contribute to the formation of MS lesions. Considering the involvement of hippocampus in MS, an attempt is made in this study to investigate the effects of vitamin D3 on behavioral process and the oxidative status in the dorsal hippocampus (CA1 area) following the induction of experimental demyelination in rats.
Materials and Methods: Animals were divided into six groups. Control group: animals received no surgery and treatment; saline group: animals received normal saline; sham group: animals received 150 μl sesame oil IP; vitamin D3 group: animals received 5 μg/kg vitamin D3 IP; lysophosphatidyl choline (LPC) group (toxic demyelination’s model): animals received LPC by stereotaxic intra-hippocampal injection of 2 μl LPC in CA1 area; Vitamin D3- treated group: animals were treated with vitamin D3 at doses of 5 μg/kg IP for 7 and 21 days post lesion. The spatial memory, biochemical parameters including catalase (CAT) activities and lipid peroxidation levels were investigated.
Results: Animals in LPC group had more deficits in spatial memory than the control group in radial arm maze. Vitamin D3 significantly improved spatial memory compared to LPC group. Also, results indicated that vitamin D3 caused a decrease in lipid peroxidation levels and an increase in CAT activities.
Conclusion: Current findings suggest that vitamin D3 may have a protective effect on cognitive deficits and oxidative stress in toxic demyelination’s model.


1.Tomassini V, Pozzilli C. Sex hormones, brain damage and clinical course of multiple sclerosis. J Neurol Sci 2009; 286: 35- 39.

2.Woodruff R, Franklin R. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/ anti-galactocerebroside: a comparative study. Glia 1999; 25:216- 228.

3.Nakatomi H, Kuriu T, Okabe S, Yamamoto S, Hatano O, Kawahara N,  et al. Regeneration of hippocampal pyramidal neurons after ischemic braininjury by recruitment of endogenous neural progenitors. Cell 2002; 110:429- 441.

4.Rao SM, Leo GL, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991; 41:685- 691.

5.Drake MA, Carra A, Allegri RF, Luetic G. Differential patterns of memoryperformance in relapsing, remitting and secondary progressivemultiple sclerosis. Neurol India 2006; 54:370-376.

6.Paulesu E, Perani D, Fazio F, Comi G, Pozzilli C, Martinelli V, et al. Functional basis of memory impairment inmultiple sclerosis: a [18F] FDG PET study. Neuroimage 1996; 4:87- 96.

7.Sicotte NL, Kern KC, Giesser BS, Arshanapalli A, Schultz A, Montag M, et al. Regional hippocampal atrophy in multiple sclerosis. Brain 2008; 131:1134-1141.

8.Storz G, Imlay JA. Oxidative stress. Curr Opin Microbiol 1999; 2:188-194.

9.Ferretti G, Bacchetti T, Principi F, Di Ludovico F, Viti B, Angeleri VA, et al. Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity. Mult Scler 2005; 11:677- 682.

10.Usatyuk PV, Natarajan V. Hydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteinsin regulating endothelial barrier function. Microvasc Res 2012; 83:45- 55.

11.Miller E, Mrowicka M, Malinowska K, Mrowicki J, Saluk-Juszczak J, Kędziora J. Effects of whole-body cryotherapy on a total antioxidative status and activities of antioxidative enzymes in blood of depressive multiple sclerosis patients. World J Biol Psychiatry 2011; 12:223-227.

12.Shin CM, Chung YH, Kim MJ, Lee EY, Kim EG, Cha CI. Age-related changes in the distribution of nitrotyrosine in the cerebral cortex and hippocampus of rats. Brain Res 2002; 931:194-199.

13.Kragt J, van Amerongen B, Killestein J, Dijkstra C, Uitdehaag B, Polman Ch, et al.  Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 2009; 15:9-15.

14.Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR, et al. Vitamin D status predicts new brain MRI activity in multiple sclerosis. Ann Neurol 2012; 72:234-240.

15.Cetinkalp S, Delen Y, Karadeniz M, Yüce G, Yilmaz C. The effect of 1alpha, 25(OH) 2D3 vitamin over oxidative stress and biochemical parameters in rats where Type 1 diabetes is formed by streptozotocin. J Diabetes Complications 2009; 23:401-408.

16.Moosmann B, Behl C. Antioxidants as treatment for neurodegenerative disorders. Expert OpinInvestig Drugs 2002; 11:1407-1435.

17.Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium,magnesium and vitamin. Med Hypotheses 1986; 21:193-200.

18.Garcion E, Sindji L, Nataf S,  Brachet P, Darcy F, Montero-Menei CN. Treatment of experimental autoimmune encephalomyelitis in rat by 1, 25-dihydroxyvitamin D3 leads to early effects within the central nervous system. Acta Neuropathol 2003; 105:438-448.

19.Mosayebi G, Ghazavi A, Payani MA. The effect of vitamin D3 on the inhibition of experimental autoimmune encephalomyelitis in C57BL/6 mice. J Iran Univ Med Sci 2006; 13:189- 196.

20.Mozafari S, Javan M, Sherafat M, Mirnajafi-Zadeh J, Heibatollahi M, Pour-Beiranvand S, et al. Analysis of structural and molecular events associated with adult rat optic chiasm and nerves demyelination and remyelination; possible role for 3rd ventricle Proliferating. Neuromol Med 2011; 13:138-150.

21.Sherafat M, Javan M, Mozafari S, Mirnajafi-Zadeh J, Motamedi F. Castration attenuates myelin repair following lysolecithin induced demyelination in rat optic chiasm: An Evaluation Using Visual evoked Potential, Marker Genes Expression and Myelin Staining. Neurochem Res 2011; 36:1887- 1895.

22.Majlessi N, Kadkhodaee M, Parviz M, Naghdi N. Serotonin depletion in rat hippocampus attenuates L-NAME-induced spatial learning deficits. Brain Res 2003; 963:244- 251.

23.Olton DS, Becker JT, Handelmann GE. Hippocampus space and memory. Behav Brain Sci 1979; 2:313-365.

24.He J, Yamada K, Nakajima A,  Kamei H, Nabeshima T. Learning and memory in two different reward tasks in a radial arm maze in rats. Behavioural Brain Res 2002; 134:139-148.

25.Tarragon E, Lopez L, Ros-Berna F, Yuste JE , Ortiz-Cullera1 V, Martin E, et al. The Radial Arm Maze (RAM) for the evaluation of working and reference memory deficits in the diurnal rodent. Octodondegus. Proc Measuring Behav 2012; 98- 100.

26.Niewoehner B, Single FN, Hvalby Q, Jensen V, Meyer zum Alten Borgloh S, Seeburg PH, et al. Impaired spatial working memory but spared spatial reference memory following functional loss of NMDA receptors in the dentate gyrus. Eur J   Neurosci 2007; 25:837- 846.

27.Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: molondeal-dehyde and 4- hydroxynonenal. Meth Enzymol 1990; 186:407- 421.

28.Aebi H. Catalase In vitro. Meth Enzymol 1984; 105:121- 126.

29.Khezri S, Javan M, Goudarzvand M, Semnanian S, Baharvand H. Dibutyryl Cyclic AMP inhibits                   the progression of experimental autoimmune encephalomyelitis and potentiates recruitment of endogenous neural stem cells. J Mol Neurosci 2013; 51:298- 306.

30.Geurts JJ, Bo L, Roosendaal SD, Hazes T, Daniëls R, Barkhof F, et al. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 2007; 66:819- 827.

31.Makinodan M, Tatsumi K, Okuda H, Manabe T, Yamauchi T, Noriyama Y, et al. Lysophosphatidyl-choline induces delayed myelination in the juvenile ventral hippocampus and behavioral alterations in adulthood. Neuroche Int 2008; 53:374- 381.

32.Haider L, Fischer MT, Frischer JM, Bauer J, Höftberger R, Botond G, et al. Oxidative damage in multiple sclerosis lesions. Brain 2011; 134:1914-1924.

33.Cantorna MT, Hayes CE, Deluca HF. 1,25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model ofmultiple sclerosis. Proc Natl Acad Sci USA 1996; 93:7861-7864.

34.Emerit J, Edeas M, Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 2004; 58:39- 46.

35.Mirshafiey A, Mohsenzadegan M. Antioxidant therapy in multiple sclerosis. Immunopharmacol Immunotoxicol 2009; 31:13- 29.

36.Uzar E, Koyuncuoglu HR, Uz E, Yilmaz HR, Kutluhan S, Kilbas S, et al. The activities of antioxidant enzymes and the level of malondialdehyde in cerebellum of rats subjected to methotrexate: protective effect of caffeic acid phenethyl ester. Mol Cell Biochem 2006; 291:63-68.

37.Ortiz GG, Macias-Islas MA, Pacheco-Moise´s FP, Cruz-Ramos JA, Sustersik S, Barba EA, et al. Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis. Dis Markers 2009; 26:35-39.

38.Mitosek-Szewczyk K, Gordon-Krajcer W, Walendzik P, Stelmasiak Z. Free radical peroxidation products in cerebrospinal fluid and serum of patients with multiple sclerosis after glucocorticoid therapy. Folia Neuropathol 2010; 48:116- 122.

39.Abdel-Salam OM, Khadrawy YA, Salem NA, Sleem AA. Oxidative stress in a model of toxic demyelination in rat brain: the effect of piracetam and vinpocetine. Neurochem Res 2011; 36:1062-1072.

40.Chen KB, Lin AM, Chiu TH. Systemic vitamin D3 attenuated oxidative injuries in the locus coeruleus of rat brain. Ann N Y Acad Sci 2003; 993:313-324.

41.Garcion E, Wion-Barbot N, Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002; 13:100-105.

42.French HM, Reid M, Mamontov P, Simmons RA, Grinspan JB. Oxidative stress disrupts oligodendrocyte maturation.  J Neurosci Res 2009; 87:3076-3087.

43.Ruuls SR, Bauer J, Sontrop K, Huitinga I, 't Hart BA, Dijkstra CD. Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 1995; 56:207-217.

44.Goudarzvand M, Javan M, Mirnajafi-Zadeh J, Mozafari S, Tiraihi T. Vitamins E and D3 attenuate demyelination and potentiate remyelination processes of hippocampal formation of rats following local Injection of ethidium bromide. Cell Mol Neurobiol 2010; 30:289- 299.

45.Ibi M, Sawada H, Nakanishi M,  Kume T, Katsuki H, Kaneko S, et al. Protective effects of 1 alpha,25-(OH)(2)D-3 against the neurotoxicity of glutamate and reactive oxygen species in mesencephali culture. Neuropharmacology 2001; 40:761-771.

46.Schreibelt G, Musters RJ, Reijerkerk A, de Groot LR, van der Pol SM, Hendrikx EM, et al. Lipoic acid affects cellular migration into the central nervous system and stabilizes blood–brain barrier integrity. J Immunol 2006; 177:2630-2637.

47.Benedict RH, Cookfair D, Gavett R, Gunther M, Munschauer F, Garg N, et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006; 12:549-558.

48.Broadbent NJ, Squire LR, Clark RE. Spatial memory, recognition memory and hippocampus. Proc Natl Acad Sci USA 2004; 101:14515-14520.

49.Coyle JT, Puttfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science 1993; 262:689-695.

50.Kim DY, Hao J, Liu R, Turner G, Shi FD, Rho JM. Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis. PLoS One 2012; 7:e35476.

51.Nizri E, Irony-Tur-Sinai M, Faranesh N, Lavon I, Lavi E, Weinstock M, et al. Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine. J Neuroimmunol 2008; 203:12-22.

52.Ziehn MO, Avedisian AA, Tiwari-Woodruff S, Voskuhl RR. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalo-myelitis, EAE. Lab Invest 2010; 90:774-786.

53.Taghizadeh M, Talaei SA, Salami M. Vitamin D deficiency impairs spatial learning in adult rats. Iran Biomed J 2013; 17:42-48.

54.Buell JS, Dawson-Hughes B. Vitamin D and neurocognitive dysfunction: Preventing Decline? Mol Aspects Med 2008; 29:415-422.

55.Becker A, Eyles DW, McGrath JJ, Grecksch G. Transient prenatal vitamin D deficiency is associated with subtle alterations in learning and memory functions in adult rats. Behav Brain Res 2005; 161:306-312.

56.Annweiler C, Schott AM, Rolland Y, Blain H, Herrmann FR, Beauchet O. Dietary intake of vitamin Dand cognition in older women: a large populationbased study. Neurology 2010; 75:1810-1816.

57.Neveu I, Naveilhan P, Baudet C, Brachet P, Metsis M. 1,25- dihydroxyvitamin D-3,regulates NT-3,NT-4 but not bonf messenger-RNA in astrocyes. Neuroreport 1994; 6:124-126.